These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23726016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
    Tanaka Y, Ito Y, Yoshizawa S, Fujimoto H, Gotoh M, Tauchi T, Kimura Y, Ohyashiki K.
    Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
    Osterborg A, Karlsson C, Lundin J.
    Curr Hematol Malig Rep; 2009 Jan; 4(1):47-53. PubMed ID: 20425438
    [Abstract] [Full Text] [Related]

  • 7. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai KR.
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A, Willekens C, Dupuis J, Royer B, Ysebaert L, De Guibert S, Michallet AS, Feugier P, Guieze R, Levy V, Delmer A.
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A.
    Ann Saudi Med; 2008 Mar; 28(5):382-5. PubMed ID: 18779631
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
    Zaja F, Vianelli N, Sperotto A, Patriarca F, Tani M, Marin L, Tiribelli M, Candoni A, Baccarani M, Fanin R.
    Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
    [Abstract] [Full Text] [Related]

  • 19. [Disseminated zygomycosis in a patient with chronic lymphocytic leukemia].
    Sanz-Bueno J, Castellanos-González M, Rodríguez-Peralto JL, Rivera R.
    Med Clin (Barc); 2013 Jun 04; 140(11):e21. PubMed ID: 23537740
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.